Biobetters & Biosimilars: Technologies and Development Strategies

December 14, 2011 8:12 AM


IBS Life Sciences is organizing the Biobetters & Biosimilars: Technologies and Development Strategies Conference in San Diego, California between 29 February-2 March 2012.

We are mainly posting events from the Europe but if you are in the States and looking for a biosimilars event, this might be the right address for you.

Some of the key topics are:

  • Fc engineering as a low-risk approach to improved performance antibodies
  • Creating biobetters with enhanced ADCC activity, reduced CDC activity, optimal biophysical properties and reduced target internalization
  • Novel formulations for non-invasive delivery of biosimilars and biobetters
  • Novel methods to reduce immunogenicity and induce tolerance
  • Value proposition of biobetters vs. biosimilars: considerations for developers
  • The role of CQAs and QbD in comparability assessment and biosimilar development
  • Comparability within a single product vs. biosimilarity between 2 products
  • Development of biobetters/biosimilars in China
If you are interested, the website of the conference is http://www.ibclifesciences.com/biobetters

Comments are closed

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!